Saturday, April 9, 2016

Despite Advances in Hepatitis C Treatment, More Research Needed (Video)

 Despite Advances in Hepatitis C Treatment, More Research Needed (Video)
By Barbara Jungwirth


April 8, 2016

On behalf of IFARA, Liz Highleyman, editor-in-chief of, spoke with Jurgen Rockstroh, M.D., Kenneth Sherman, M.D., Ph.D., and Dost Sarpel, M.D., about research on the treatment of hepatitis B and C. One trial found that a six-week course of ledipasvir and sofosbuvir (Harvoni) cleared acute hepatitis C (HCV) in most patients, except for those with very high viral loads. Another study showed that a new HIV drug, cenicriviroc, can inhibit the hepatic fibrosis often experienced by people living with HIV. Risk factors for HCV treatment failure were the focus of a third study. HCV reinfection, as well as a higher risk for developing liver cancer after being cured of this virus, are other areas of concern, as is the need for drugs to re-treat those for whom HCV treatment did not work the first time around.

Watch the video to learn more

No comments:

Post a Comment